Infectious and inflammatory skin diseases caused by the herpes simplex virus types I and II (including genital herpes).
Outwardly. The gel is applied in a thin layer to the affected areas of the skin and / or mucous membranes 5 times a day. Duration of treatment is 4-5 days. The course of treatment can be extended up to 10 days.
Intravaginally. A small amount of gel is injected vaginally and evenly distributed in a thin layer along the walls of the vagina. Treatment continues until the clinical manifestations disappear completely.
Active substance: PanavirЃ (purified extract of the shoots of the plant Solanum tuberosum) - 0.002 g per 100 g.
Excipients: glycerin, polyethylene oxide 400, polyethylene oxide 4000, ethyl alcohol; sodium hydroxide, lanthanum nitrate, purified water
Hypersensitivity to the components of the drug,
Pharmacological properties : PanavirЃ is an antiviral drug for external use, has a virostatic effect. Active against Herpes simplex viruses types I and II. PanavirЃ inhibits viral replication and polymerase reactions by blocking the synthesis of viral DNA in the affected skin cells.
The appearance of rapidly passing redness and itching of the skin at the site of application of the gel is possible.
It is recommended to start treatment at the earliest possible stage of the disease, at the first signs (itching, tingling, redness, feeling of tension), in this case, the development of the vesicular stage of the disease can be completely prevented.
PanavirЃ gel cannot be used in ophthalmology. When applying the gel to the face, avoid contact with the eyes.